Related Experiment Video
Updated: Apr 12, 2026

09:46
Accessing the Cytotoxicity and Cell Response to Biomaterials
Published on: July 8, 2021
4.8K
Bioactivity of a Calcium Silicate-based Endodontic Cement (BioRoot RCS): Interactions with Human Periodontal Ligament
Jean Camps1, Charlotte Jeanneau2, Ikbale El Ayachi2
1Assistance Publique-Hôpitaux de Marseille, Service d'Odontologie, Hôpital Timone, Marseille, France.
Journal of Endodontics
|May 24, 2015
Summary
Newly developed tricalcium silicate cement (BioRoot RCS) shows less toxicity and higher bioactivity compared to zinc oxide-eugenol sealer (PCS) in preclinical studies on human periodontal ligament cells.
Area of Science:
- Endodontics
- Biomaterials Science
- Cell Biology
Background:
- Tricalcium silicate cements are bioactive, promoting hard tissue formation in dental pulp and bone.
- Root canal filling materials interact with periapical tissues, influencing healing.
- Evaluating new materials like BioRoot RCS against standard sealers (PCS) is crucial for endodontic treatment.
Purpose of the Study:
- To compare the bioactivity and cellular effects of a new tricalcium silicate cement (BioRoot RCS) with a standard zinc oxide-eugenol sealer (PCS).
- To assess the interaction of these root canal sealers with human periodontal ligament (PDL) cells.
Main Methods:
- Human PDL cells were exposed directly to BioRoot RCS and PCS to assess cell viability.
- An in vitro tooth model was used, with root canals filled and apices immersed in culture medium.
- Conditioned media effects on PDL cell proliferation (MTT assay) and growth factor secretion (ELISA) were quantified.
Main Results:
- BioRoot RCS demonstrated significantly less toxic effects on PDL cells compared to PCS.
- BioRoot RCS induced a higher secretion of angiogenic and osteogenic growth factors than PCS.
- These findings indicate enhanced cellular response to the tricalcium silicate cement.
Conclusions:
- The calcium silicate cement (BioRoot RCS) exhibits superior bioactivity compared to the zinc oxide-eugenol sealer (PCS) when interacting with human PDL cells.
- These preclinical findings suggest BioRoot RCS as a promising alternative for root canal sealing.
- Further clinical studies are warranted to confirm these enhanced bioactivity outcomes.

